91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

Medicinal 91AV Residential School 2014, China

21 - 23 November 2014, Shanghai, China


Introduction
The objective of the residential school is to strengthen excellence in medicinal chemistry by highlighting best practice and facilitating understanding of the factors governing modern drug discovery. Its purpose is to develop medicinal chemistry skills of chemists internationally, in particular those based in Asia. The residential school provides an outstanding programme of lectures, case studies, hands-on tutorial sessions to cover aspects of drug discovery. Delegates have the opportunity to ask questions after each talk but also during the tutorial sessions. Delegates will be exposed to new areas of research as well as learning from numerous case studies highlighting how the process comes together to overcome the challenges of bringing a drug to market.

The Medicinal 91AV Residential School forms part of the 91AV's on-going programme of activities relating to human health and supporting skills development for drug discovery.
Throughout the 3 day course, there are a series of lectures, case histories and tutorials. Delegates split into small tutorial groups to maximise learning opportunities and networking amongst speakers and delegates. The tutorials allow attendees to put into practice what they learn via hands-on examples and discussions with the tutors. Speakers and tutors are available for informal discussions and interactions throughout the course.

Themes
The residential school covered the following topics:

Drug discovery process
Common drug targets/receptor
Target identification and validation
Structure-guided drug design
Pharmacokinetics & drug metabolism
Computational chemistry
Quantitative structure-activity relationship
Small molecules & lead development
Lead optimisation strategies
Toxicology in drug discovery
Drug discovery case histories
 
Speakers
  • Kevin Chen WuXi App Tech, China
  • Jonathan Connick Merck & Co Inc, China
  • Andy Davis Astra Zeneca, Sweden
  • Adrian Hall UCB Pharma, Belgium
  • Robert Ings RMI Pharmacokinetics, United States
  • Paul Leeson GlaxoSmithKline, United Kingdom
  • Cheng Luo Shanghai Institute of Materia Medica, China
  • Ian Storer Pfizer Neusentis, United Kingdom
  • Wei Tang ChemPartner, China
  • Andrew Thomas Roche, Switzerland
  • Ming-Qiang Zhang Amgen, China
  • Bin Zou Novartis Institute for Biomedical Research, Singapore

Venue
Shanghai Institute of Materia Medica (SIMM)

Shanghai Institute of Materia Medica (SIMM), Zuchongzhi Rd, Pudong, Shanghai, 201203  , China

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*